HIVE Net Profit Margin vs Pretax Profit Margin Analysis

HIVE Stock

USD 2.52 0.07 2.70%

HIVE Blockchain financial indicator trend analysis is much more than just examining HIVE Blockchain Tech latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HIVE Blockchain Tech is a good investment. Please check the relationship between HIVE Blockchain Net Profit Margin and its Pretax Profit Margin accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Net Profit Margin vs Pretax Profit Margin

Net Profit Margin vs Pretax Profit Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HIVE Blockchain Tech Net Profit Margin account and Pretax Profit Margin. At this time, the significance of the direction appears to have totally related.

The correlation between HIVE Blockchain's Net Profit Margin and Pretax Profit Margin is 1.0. Overlapping area represents the amount of variation of Net Profit Margin that can explain the historical movement of Pretax Profit Margin in the same time period over historical financial statements of HIVE Blockchain Technologies, assuming nothing else is changed. The correlation between historical values of HIVE Blockchain's Net Profit Margin and Pretax Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Profit Margin of HIVE Blockchain Technologies are associated (or correlated) with its Pretax Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pretax Profit Margin has no effect on the direction of Net Profit Margin i.e., HIVE Blockchain's Net Profit Margin and Pretax Profit Margin go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Profit Margin

The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.

Pretax Profit Margin

Most indicators from HIVE Blockchain's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HIVE Blockchain Tech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

The current year's Selling General Administrative is expected to grow to about 23 M, whereas Tax Provision is forecasted to decline to about 315.7 K.

	2023	2024 (projected)
Cost Of Revenue	159.8M	167.8M
Research Development	41.0M	39.2M

Cost Of Revenue Research Development

HIVE Blockchain fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Common Stock Total Equity	Property Plant And Equipment Gross	Current Deferred Revenue	Good Will	Non Current Liabilities Total
Total Assets		0.93	0.43	0.91	1.0	0.96	0.8	-0.48	0.55	0.34	0.99	0.83	0.63	0.58	0.79	0.96	0.13	0.92	0.99	0.5	0.85	0.62	0.85	0.65	-0.37	-0.15
Short Long Term Debt Total	0.93		0.49	0.96	0.9	0.91	0.83	-0.7	0.44	0.42	0.92	0.72	0.61	0.62	0.88	0.9	0.08	0.98	0.92	0.49	0.95	0.66	0.88	0.71	-0.57	-0.22
Other Current Liab	0.43	0.49		0.41	0.42	0.41	0.41	-0.18	-0.21	0.19	0.44	0.41	0.23	0.5	0.25	0.35	-0.26	0.42	0.4	0.43	0.36	-0.09	0.32	0.04	-0.25	-0.57
Total Current Liabilities	0.91	0.96	0.41		0.88	0.95	0.93	-0.75	0.48	0.18	0.91	0.59	0.41	0.57	0.89	0.9	0.09	0.95	0.88	0.43	0.97	0.64	0.96	0.72	-0.63	-0.23
Total Stockholder Equity	1.0	0.9	0.42	0.88		0.96	0.77	-0.42	0.58	0.33	0.99	0.86	0.62	0.59	0.75	0.95	0.16	0.88	0.98	0.53	0.82	0.6	0.82	0.63	-0.33	-0.16
Property Plant And Equipment Net	0.96	0.91	0.41	0.95	0.96		0.92	-0.54	0.54	0.11	0.98	0.69	0.41	0.54	0.78	0.95	0.11	0.91	0.92	0.47	0.88	0.57	0.94	0.61	-0.48	-0.16
Net Debt	0.8	0.83	0.41	0.93	0.77	0.92		-0.61	0.36	-0.16	0.83	0.39	0.09	0.42	0.7	0.84	-0.03	0.83	0.73	0.32	0.84	0.45	0.98	0.49	-0.63	-0.14
Retained Earnings	-0.48	-0.7	-0.18	-0.75	-0.42	-0.54	-0.61		-0.36	-0.24	-0.47	-0.17	-0.27	-0.44	-0.88	-0.49	-0.17	-0.7	-0.49	-0.19	-0.86	-0.6	-0.64	-0.77	0.57	0.31
Accounts Payable	0.55	0.44	-0.21	0.48	0.58	0.54	0.36	-0.36		0.2	0.58	0.58	0.39	0.53	0.55	0.44	0.83	0.38	0.5	0.56	0.52	0.51	0.39	0.63	-0.05	-0.11
Cash	0.34	0.42	0.19	0.18	0.33	0.11	-0.16	-0.24	0.2		0.27	0.63	0.92	0.41	0.42	0.22	0.2	0.38	0.43	0.34	0.32	0.44	-0.03	0.47	0.02	-0.16
Non Current Assets Total	0.99	0.92	0.44	0.91	0.99	0.98	0.83	-0.47	0.58	0.27		0.82	0.55	0.63	0.76	0.94	0.18	0.89	0.95	0.57	0.84	0.6	0.86	0.63	-0.39	-0.2
Non Currrent Assets Other	0.83	0.72	0.41	0.59	0.86	0.69	0.39	-0.17	0.58	0.63	0.82		0.82	0.72	0.55	0.68	0.35	0.64	0.82	0.73	0.57	0.53	0.46	0.54	-0.06	-0.27
Cash And Short Term Investments	0.63	0.61	0.23	0.41	0.62	0.41	0.09	-0.27	0.39	0.92	0.55	0.82		0.44	0.58	0.53	0.19	0.59	0.71	0.37	0.49	0.56	0.22	0.59	0.01	-0.09
Net Receivables	0.58	0.62	0.5	0.57	0.59	0.54	0.42	-0.44	0.53	0.41	0.63	0.72	0.44		0.59	0.36	0.55	0.46	0.5	0.95	0.61	0.48	0.42	0.59	-0.3	-0.75
Common Stock Shares Outstanding	0.79	0.88	0.25	0.89	0.75	0.78	0.7	-0.88	0.55	0.42	0.76	0.55	0.58	0.59		0.76	0.24	0.88	0.8	0.38	0.97	0.75	0.76	0.89	-0.55	-0.31
Other Current Assets	0.96	0.9	0.35	0.9	0.95	0.95	0.84	-0.49	0.44	0.22	0.94	0.68	0.53	0.36	0.76		-0.06	0.94	0.97	0.26	0.83	0.59	0.89	0.6	-0.4	0.02
Other Stockholder Equity	0.13	0.08	-0.26	0.09	0.16	0.11	-0.03	-0.17	0.83	0.2	0.18	0.35	0.19	0.55	0.24	-0.06		-0.04	0.05	0.63	0.18	0.21	-0.04	0.36	0.02	-0.28
Total Liab	0.92	0.98	0.42	0.95	0.88	0.91	0.83	-0.7	0.38	0.38	0.89	0.64	0.59	0.46	0.88	0.94	-0.04		0.93	0.31	0.94	0.66	0.9	0.69	-0.56	-0.09
Total Current Assets	0.99	0.92	0.4	0.88	0.98	0.92	0.73	-0.49	0.5	0.43	0.95	0.82	0.71	0.5	0.8	0.97	0.05	0.93		0.4	0.84	0.64	0.8	0.67	-0.34	-0.08
Short Term Debt	0.5	0.49	0.43	0.43	0.53	0.47	0.32	-0.19	0.56	0.34	0.57	0.73	0.37	0.95	0.38	0.26	0.63	0.31	0.4		0.43	0.35	0.31	0.41	-0.17	-0.64
Common Stock	0.85	0.95	0.36	0.97	0.82	0.88	0.84	-0.86	0.52	0.32	0.84	0.57	0.49	0.61	0.97	0.83	0.18	0.94	0.84	0.43		0.69	0.87	0.81	-0.63	-0.29
Common Stock Total Equity	0.62	0.66	-0.09	0.64	0.6	0.57	0.45	-0.6	0.51	0.44	0.6	0.53	0.56	0.48	0.75	0.59	0.21	0.66	0.64	0.35	0.69		0.59	0.87	-0.16	-0.12
Property Plant And Equipment Gross	0.85	0.88	0.32	0.96	0.82	0.94	0.98	-0.64	0.39	-0.03	0.86	0.46	0.22	0.42	0.76	0.89	-0.04	0.9	0.8	0.31	0.87	0.59		0.57	-0.63	-0.07
Current Deferred Revenue	0.65	0.71	0.04	0.72	0.63	0.61	0.49	-0.77	0.63	0.47	0.63	0.54	0.59	0.59	0.89	0.6	0.36	0.69	0.67	0.41	0.81	0.87	0.57		-0.27	-0.31
Good Will	-0.37	-0.57	-0.25	-0.63	-0.33	-0.48	-0.63	0.57	-0.05	0.02	-0.39	-0.06	0.01	-0.3	-0.55	-0.4	0.02	-0.56	-0.34	-0.17	-0.63	-0.16	-0.63	-0.27		0.17
Non Current Liabilities Total	-0.15	-0.22	-0.57	-0.23	-0.16	-0.16	-0.14	0.31	-0.11	-0.16	-0.2	-0.27	-0.09	-0.75	-0.31	0.02	-0.28	-0.09	-0.08	-0.64	-0.29	-0.12	-0.07	-0.31	0.17

Click cells to compare fundamentals

HIVE Blockchain Account Relationship Matchups

HIVE Blockchain fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	29.1M	178.3M	452.3M	196.1M	225.5M	236.8M
Short Long Term Debt Total	5.1M	30.9M	43.3M	35.4M	40.7M	42.8M
Other Current Liab	830.7K	73.1K	1.0M	4.3M	3.9M	4.1M
Total Current Liabilities	7.2M	9.9M	26.2M	21.9M	25.2M	26.4M
Total Stockholder Equity	21.1M	134.5M	389.1M	148.8M	171.1M	179.7M
Property Plant And Equipment Net	8.9M	24.7M	190.1M	98.2M	112.9M	118.6M
Net Debt	(73.1K)	(9.4M)	38.0M	31.0M	35.7M	37.5M
Retained Earnings	(173.2M)	(130.6M)	(60.2M)	(296.7M)	(267.0M)	(253.6M)
Accounts Payable	2.1M	3.5M	12.4M	6.9M	7.9M	4.9M
Cash	5.1M	40.3M	5.3M	4.4M	5.0M	5.3M
Non Current Assets Total	10.8M	70.8M	252.0M	113.6M	130.7M	137.2M
Non Currrent Assets Other	1.6M	45.5M	61.5M	15.4M	17.7M	18.2M
Cash And Short Term Investments	5.1M	41.3M	22.3M	7.2M	8.3M	6.8M
Net Receivables	9.1M	6.8M	8.0M	9.4M	10.8M	11.3M
Common Stock Shares Outstanding	65.4M	73.3M	84.8M	82.9M	95.3M	100.1M
Liabilities And Stockholders Equity	29.1M	178.3M	452.3M	196.1M	225.5M	236.8M
Other Current Assets	3.5M	57.5M	176.8M	75.3M	86.5M	90.9M
Other Stockholder Equity	283.3M	5.7M	5.2M	35.6M	41.0M	44.8M
Total Liab	8.0M	43.9M	63.2M	47.3M	54.4M	57.1M
Total Current Assets	18.3M	107.5M	200.3M	82.5M	94.9M	99.6M
Short Term Debt	4.3M	6.3M	12.8M	10.7M	12.3M	12.9M
Common Stock	188.5M	259.9M	413.7M	419.2M	482.1M	506.2M
Property Plant And Equipment Gross	8.9M	24.7M	342.8M	273.7M	314.7M	330.5M
Accumulated Other Comprehensive Income	5.7M	5.2M	35.6M	26.3M	30.2M	31.7M
Non Current Liabilities Total	775.5K	34.0M	37.1M	25.4M	22.9M	22.9M
Inventory	3.5M	57.5M	170.0M	65.9M	75.8M	41.6M
Short Term Investments	3.5M	981.7K	17.0M	2.9M	2.6M	2.5M
Net Tangible Assets	21.9M	21.1M	133.9M	388.7M	447.0M	469.4M
Net Invested Capital	23.8M	162.3M	419.7M	173.8M	199.8M	175.2M
Net Working Capital	11.1M	97.7M	174.1M	60.6M	69.7M	71.8M
Property Plant Equipment	12.1M	8.7M	24.6M	190.1M	218.7M	229.6M
Short Long Term Debt	2.7M	4.4M	10.6M	8.4M	9.6M	6.4M
Capital Stock	188.5M	259.9M	413.7M	419.2M	482.1M	323.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
BAC	Bank of America
GM	General Motors

When determining whether HIVE Blockchain Tech is a strong investment it is important to analyze HIVE Blockchain's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HIVE Blockchain's future performance. For an informed investment choice regarding HIVE Stock, refer to the following important reports:

How To Invest In HIVE

Details

Is HIVE Stock a good investment?

Details

What is HIVE Blockchain's Net Worth?

Details

Largest Asset Management & Custody Banks Companies

View

Largest Financial Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for HIVE Stock analysis

When running HIVE Blockchain's price analysis, check to measure HIVE Blockchain's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HIVE Blockchain is operating at the current time. Most of HIVE Blockchain's value examination focuses on studying past and present price action to predict the probability of HIVE Blockchain's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HIVE Blockchain's price. Additionally, you may evaluate how the addition of HIVE Blockchain to your portfolios can decrease your overall portfolio volatility.

	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Commodity Directory Find actively traded commodities issued by global exchanges
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges

Is HIVE Blockchain's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HIVE Blockchain. If investors know HIVE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HIVE Blockchain listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.217

Earnings Share

(0.45)

Revenue Per Share

1.121

Quarterly Revenue Growth

1.183

Return On Assets

(0.07)

The market value of HIVE Blockchain Tech is measured differently than its book value, which is the value of HIVE that is recorded on the company's balance sheet. Investors also form their own opinion of HIVE Blockchain's value that differs from its market value or its book value, called intrinsic value, which is HIVE Blockchain's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HIVE Blockchain's market value can be influenced by many factors that don't directly affect HIVE Blockchain's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between HIVE Blockchain's value and its price as these two are different measures arrived at by different means. Investors typically determine if HIVE Blockchain is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HIVE Blockchain's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HIVE Net Profit Margin vs Pretax Profit Margin Analysis

Net Profit Margin vs Pretax Profit Margin

Net Profit Margin vs Pretax Profit Margin Correlation Analysis

Correlation Coefficient

Net Profit Margin

Pretax Profit Margin

HIVE Blockchain fundamental ratios Correlations

HIVE Blockchain Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HIVE Blockchain fundamental ratios Accounts

Also Currently Popular

Complementary Tools for HIVE Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.98	Short Long Term Debt Total
Total Current Assets	+ 0.98	Total Stockholder Equity

Common Stock Shares Outstanding	- 0.88	Retained Earnings
Common Stock	- 0.86	Retained Earnings
Current Deferred Revenue	- 0.77	Retained Earnings
Non Current Liabilities Total	- 0.75	Net Receivables
Retained Earnings	- 0.75	Total Current Liabilities
Total Liab	- 0.7	Retained Earnings